ATF2
Cyclic AMP-dependent transcription factor ATF-2
Also known as: ATF2_HUMAN, CRE-BP1, CREB2, HB16, TREB7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15336
- Gene
- ATF2
- Ensembl
- ENSG00000115966
- Chromosome
- 2
- Canonical length
- 505 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a transcription factor that is a member of the leucine zipper family of DNA binding proteins. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions This protein binds to the cAMP-responsive element (CRE), an octameric palindrome. It forms a homodimer or a heterodimer with c-Jun and stimulates CRE-dependent transcription. This protein is also a histone acetyltransferase (HAT) that specifically acetylates histones H2B and H4 in vitro; thus it may represent a class of sequence-specific factors that activate transcription by direct effects on chromatin components. The encoded protein may also be involved in cell's DNA damage response independent of its role in transcriptional regulation. Several alternatively spliced transcript variants have been found for this gene [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
505 residues, UniProt reviewed canonical sequence.
>P15336|ATF2
1 MKFKLHVNSA RQYKDLWNMS DDKPFLCTAP GCGQRFTNED HLAVHKHKHE MTLKFGPARN
61 DSVIVADQTP TPTRFLKNCE EVGLFNELAS PFENEFKKAS EDDIKKMPLD LSPLATPIIR
121 SKIEEPSVVE TTHQDSPLPH PESTTSDEKE VPLAQTAQPT SAIVRPASLQ VPNVLLTSSD
181 SSVIIQQAVP SPTSSTVITQ APSSNRPIVP VPGPFPLLLH LPNGQTMPVA IPASITSSNV
241 HVPAAVPLVR PVTMVPSVPG IPGPSSPQPV QSEAKMRLKA ALTQQHPPVT NGDTVKGHGS
301 GLVRTQSEES RPQSLQQPAT STTETPASPA HTTPQTQSTS GRRRRAANED PDEKRRKFLE
361 RNRAAASRCR QKRKVWVQSL EKKAEDLSSL NGQLQSEVTL LRNEVAQLKQ LLLAHKDCPV
421 TAMQKKSGYH TADKDDSSED ISVPSSPHTE AIQHSSVSTS NGVSSTSKAE AVATSVLTQM
481 ADQSTEPALS QIVMAPSSQS QPSGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 30 nTPM
- cerebellum: 27 nTPM
- thymus: 26 nTPM
- liver: 25 nTPM
- cervix: 24 nTPM
- cerebral cortex: 23 nTPM
Single-cell type
- late spermatids: 230 nCPM
- lactotrophs: 162 nCPM
- thyrotrophs: 158 nCPM
- corticotrophs: 150 nCPM
- neutrophil progenitors: 147 nCPM
- pituicytes/fscs: 140 nCPM
Immune cell
- basophil: 35 nTPM
- T-reg: 24 nTPM
- MAIT T-cell: 24 nTPM
- myeloid DC: 22 nTPM
- naive CD8 T-cell: 22 nTPM
- memory CD8 T-cell: 21 nTPM
Brain region
- cerebellum: 70 nTPM
- cerebral cortex: 67 nTPM
- white matter: 62 nTPM
- basal ganglia: 58 nTPM
- pons: 56 nTPM
- hypothalamus: 54 nTPM
ReferencesPubMed · IEDB
Publications for ATF2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Autoantibody against activating transcription factor-2 in patients with systemic sclerosis.
2009 · Clin Exp Rheumatol · RCR 0.3 · 9 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 2.35
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adipose tissue development
- apoptotic process involved in development
- BMP signaling pathway
- brainstem development
- brown fat cell proliferation
- cellular response to anisomycin
- cellular response to leucine starvation
- cellular response to oxidative stress
- cellular response to virus
- DNA damage response
- energy homeostasis
- facial nucleus development
- growth plate cartilage chondrocyte differentiation
- growth plate cartilage chondrocyte proliferation
- hematopoietic progenitor cell differentiation
- hepatocyte apoptotic process
- in utero embryonic development
- intrinsic apoptotic signaling pathway in response to hypoxia
- JNK cascade
- lipid metabolic process
- liver development
- mitotic intra-S DNA damage checkpoint signaling
- motor neuron apoptotic process
- mRNA transcription by RNA polymerase II
- negative regulation of angiogenesis
- negative regulation of transcription by RNA polymerase II
- neurofilament cytoskeleton organization
- NK T cell differentiation
- outflow tract morphogenesis
- p38MAPK cascade
- peptidyl-threonine phosphorylation
- positive regulation of cardiac muscle myoblast proliferation
- positive regulation of DNA-binding transcription factor activity
- positive regulation of gene expression
- positive regulation of mitochondrial membrane permeability involved in apoptotic process
- positive regulation of transcription by RNA polymerase II
- positive regulation of transforming growth factor beta2 production
- protein import into nucleus
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- response to osmotic stress
- temperature homeostasis
- transcription initiation-coupled chromatin remodeling
- vacuole organization
- white fat cell differentiation
- abducens nucleus development
- detection of cell density
- hypoglossal nucleus development
Molecular functions
- cAMP response element binding
- cAMP response element binding protein binding
- cis-regulatory region sequence-specific DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- histone acetyltransferase activity
- histone H2B acetyltransferase activity
- histone H4 acetyltransferase activity
- identical protein binding
- leucine zipper domain binding
- promoter-specific chromatin binding
- protein heterodimerization activity
- protein homodimerization activity
- protein kinase binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
- chromatin
- cytoplasm
- mitochondrial outer membrane
- nucleoplasm
- nucleus
- RNA polymerase II transcription regulator complex
- site of double-strand break
- H4 histone acetyltransferase complex
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATF2 as an antibody target. Whether an autoantibody or antibody against ATF2 could matter depends on whether native ATF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...